Aficamten
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Aficamten, covering 2025-05-02 to 2026-08-05. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) [Phase 3]